Unpacking Lupus Treatment: How Quickly Does Anifrolumab Start Working? Insights from TULIP Trials

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in patients with Systemic Lupus Erythematosus. The episode delves into pooled data from two significant Phase III trials, TULIP-1 and TULIP-2, offering listeners a deep understanding of the effectiveness and timeline of Anifrolumab treatment.

 

Read the article: http://dx.doi.org/10.1136/lupus-2022-000761